Literature DB >> 20194497

TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.

Richard W Tsika1, Lixin Ma, Izhak Kehat, Christine Schramm, Gretchen Simmer, Brandon Morgan, Deborah M Fine, Laurin M Hanft, Kerry S McDonald, Jeffery D Molkentin, Maike Krenz, Steve Yang, Juan Ji.   

Abstract

TEA domain transcription factor-1 (TEAD-1) is essential for proper heart development and is implicated in cardiac specific gene expression and the hypertrophic response of primary cardiomyocytes to hormonal and mechanical stimuli, and its activity increases in the pressure-overloaded hypertrophied rat heart. To investigate whether TEAD-1 is an in vivo modulator of cardiac specific gene expression and hypertrophy, we developed transgenic mice expressing hemagglutinin-tagged TEAD-1 under the control of the muscle creatine kinase promoter. We show that a sustained increase in TEAD-1 protein leads to an age-dependent dysfunction. Magnetic resonance imaging revealed decreases in cardiac output, stroke volume, ejection fraction, and fractional shortening. Isolated TEAD-1 hearts revealed decreased left ventricular power output that correlated with increased betaMyHC protein. Histological analysis showed altered alignment of cardiomyocytes, septal wall thickening, and fibrosis, although electrocardiography displayed a left axis shift of mean electrical axis. Transcripts representing most members of the fetal heart gene program remained elevated from fetal to adult life. Western blot analyses revealed decreases in p-phospholamban, SERCA2a, p-CX43, p-GSK-3alpha/beta, nuclear beta-catenin, GATA4, NFATc3/c4, and increased NCX1, nuclear DYKR1A, and Pur alpha/beta protein. TEAD-1 mice did not display cardiac hypertrophy. TEAD-1 mice do not tolerate stress as they die over a 4-day period after surgical induction of pressure overload. These data provide the first in vivo evidence that increased TEAD-1 can induce characteristics of cardiac remodeling associated with cardiomyopathy and heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194497      PMCID: PMC2859535          DOI: 10.1074/jbc.M109.063057

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility.

Authors:  M Periasamy; S Huke
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

3.  Robust estimators for expression analysis.

Authors:  Earl Hubbell; Wei-Min Liu; Rui Mei
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

4.  Stretching cardiac myocytes stimulates protooncogene expression.

Authors:  I Komuro; T Kaida; Y Shibazaki; M Kurabayashi; Y Katoh; E Hoh; F Takaku; Y Yazaki
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

5.  Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene.

Authors:  M Periasamy; T D Reed; L H Liu; Y Ji; E Loukianov; R J Paul; M L Nieman; T Riddle; J J Duffy; T Doetschman; J N Lorenz; G E Shull
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

6.  Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes.

Authors:  Tomoji Maeda; Joseph R Mazzulli; Iain K G Farrance; Alexandre F R Stewart
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

7.  Targeting phospholamban by gene transfer in human heart failure.

Authors:  Federica del Monte; Sian E Harding; G William Dec; Judith K Gwathmey; Roger J Hajjar
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

Review 8.  Molecular regulation of cardiac hypertrophy.

Authors:  Sean P Barry; Sean M Davidson; Paul A Townsend
Journal:  Int J Biochem Cell Biol       Date:  2008-02-26       Impact factor: 5.085

9.  M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth.

Authors:  L R Karns; K Kariya; P C Simpson
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

Review 10.  Glycogen synthase kinase 3: a key regulator of cellular fate.

Authors:  J E Forde; T C Dale
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

View more
  24 in total

1.  Sildenafil reverses the hypertrophy of mice right ventricle caused by hypoxia but does not reverse the changes in the myosin heavy chain isoforms.

Authors:  Mukhallad A Aljanabi; Mahmoud A Alfaqih; Anwar Mohammad A Al-Khayat; Hameed N Bataineh
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-06-15

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  Age-associated alterations of cardiac structure and function in the female F344xBN rat heart.

Authors:  Jacqueline Fannin; Kevin M Rice; Srininvas Thulluri; Lucy Dornon; Ravi Kumar Arvapalli; Paulette Wehner; Eric R Blough
Journal:  Age (Dordr)       Date:  2014-07-27

4.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

Authors:  Hanrui Zhang; Brandon Morgan; Barry J Potter; Lixin Ma; Kevin C Dellsperger; Zoltan Ungvari; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

5.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.

Authors:  Lixin Ma; Rukhsana Gul; Javad Habibi; Ming Yang; Lakshmi Pulakat; Adam Whaley-Connell; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 6.  The hippo pathway in heart development, regeneration, and diseases.

Authors:  Qi Zhou; Li Li; Bin Zhao; Kun-Liang Guan
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

7.  Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy.

Authors:  Ruya Liu; Jeongkyung Lee; Byung S Kim; Qiongling Wang; Samuel K Buxton; Nikhil Balasubramanyam; Jean J Kim; Jianrong Dong; Aijun Zhang; Shumin Li; Anisha A Gupte; Dale J Hamilton; James F Martin; George G Rodney; Cristian Coarfa; Xander Ht Wehrens; Vijay K Yechoor; Mousumi Moulik
Journal:  JCI Insight       Date:  2017-09-07

8.  Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload.

Authors:  Jaemin Byun; Dominic P Del Re; Peiyong Zhai; Shohei Ikeda; Akihiro Shirakabe; Wataru Mizushima; Shigeki Miyamoto; Joan H Brown; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

9.  Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.

Authors:  E G Ames; M J Lawson; A J Mackey; J W Holmes
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

10.  Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy.

Authors:  Ning Hou; Ying Wen; Xun Yuan; Haodong Xu; Xuejun Wang; Faqian Li; Bo Ye
Journal:  Exp Mol Pathol       Date:  2017-11-15       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.